Anders Aasted Isaksen

Anders Aasted Isaksen

Auto-generated profile, based on publicly available information

Anders Aasted Isaksen

Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
AIAnders Aasted Isaksen
Anders Aasted Isaksen
ASAnnelli Sandbaek
Annelli Sandbaek
LBLasse Bjerg
Lasse Bjerg
Purpose: To validate two register-based algorithms classifying type 1 (T1D) and type 2 diabetes (T2D) in a general population using Danish register data. Patients and Methods: After linking data on prescription drug usage, hospital diagnoses, laboratory results and diabetes-specific healthcare services from nationwide healthcare registers, diabetes type was defined for all individuals in Central Denmark Region age 18– 74 years on 31 December 2018 according to two distinct register-based classifiers: 1) a novel register-based diabetes classifier incorporating diagnostic hemoglobin-A1C measurements, the Open-Source Diabetes Classifier (OSDC), and 2) an existing Danish diabetes classifier, the Register for Selected Chronic Diseases (RSCD). These classifications were validated against self-reported data from the Health in Central Denmark survey – overall and stratified by age at onset of diabetes. The source-code of both classifiers was made available in the open-source R package osdc. Results: A total of 2633 (9.0%) of 29,391 respondents reported having any type of diabetes, divided across 410 (1.4%) self-reported cases of T1D and 2223 (7.6%) cases of T2D. Among all self-reported diabetes cases, 2421 (91.9%) were classified as diabetes cases by both classifiers. In T1D, sensitivity of OSDC-classification was 0.773 [95% CI 0.730– 0.813] (RSCD: 0.700 [0.653– 0.744]) and positive predictive value (PPV) 0.943 [0.913– 0.966] (RSCD: 0.944 [0.912– 0.967]). In T2D, sensitivity of OSDC-classification was 0.944 [0.933– 0.953] (RSCD: 0.905 [0.892– 0.917]) and PPV 0.875 [0.861– 0.888] (RSCD: 0.898 [0.884– 0.910]). In age at onset-stratified analyses of both classifiers, sensitivity and PPV were low in individuals with T1D onset after age 40 and T2D onset before age 40. Conclusion: Both register-based classifiers identified valid populations of T1D and T2D in a general population, but sensitivity was substantially higher in OSDC compared to RSCD. Register-classified diabetes type in cases with atypical age at onset of diabetes should be interpreted with caution. The validated, open-source classifiers provide robust and transparent tools for researchers.

25 November 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
AIAnders Aasted Isaksen
Anders Aasted Isaksen
JSJonas Rosborg Schaarup
Jonas Rosborg Schaarup
LBLasse Bjerg
Lasse Bjerg
AHAdam Hulman
Adam Hulman
The public perception of artificial intelligence (AI) in healthcare is key to its large-scale acceptance and implementation. This study investigated how exposure to ChatGPT changed public perception of AI in healthcare, using baseline and follow-up data from 5899 survey participants reporting their perception of AI in 2022 (before ChatGPT’s launch) and 2024, and ChatGPT use in 2024. Multinomial multivariate logistic regression was used to model how exposure to ChatGPT use affected changes in perception of AI. At follow-up, 1195 individuals (20%) had been exposed to ChatGPT use, which was associated with higher odds of changing perception of AI to beneficial (OR 3.21 [95% CI: 2.34–4.40]) among individuals who were unsure at baseline, and lower odds of changing to uncertainty from more defined baseline perceptions. This study demonstrates the potential for reducing uncertainty and improving public perception of AI in healthcare through exposure to AI tools.

18 October 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
AIAnders Aasted Isaksen
Anders Aasted Isaksen
ASAnnelli Sandbæk
Annelli Sandbæk
MSMette Vinther Skriver
Mette Vinther Skriver
GAGregers Stig Andersen
Gregers Stig Andersen
LBLasse Bjerg
Lasse Bjerg
The prevalence of type 2 diabetes (T2D) is higher in migrants compared to native populations in many countries, but the evidence on disparities in T2D care in migrants is inconsistent. Therefore, this study aimed to examine this in Denmark. In a cross-sectional, register-based study on 254,097 individuals with T2D, 11 indicators of guideline-level care were analysed: a) monitoring: hemoglobin-A1c (HbA1c), low-density lipoprotein cholesterol (LDL-C), screening for diabetic nephropathy, retinopathy, and foot disease, b) biomarker control: HbA1c and LDL-C levels, and c) pharmacological treatment: glucose-lowering drugs (GLD), lipid-lowering drugs, angiotensin-converting enzyme-inhibitors/angiotensin receptor blockers, and antiplatelet therapy. Migrants were grouped by countries of origin: Middle East, Europe, Turkey, Former Yugoslavia, Pakistan, Sri Lanka, Somalia, Vietnam. In all migrant groups except the Europe-group, T2D was more prevalent than in native Danes (crude relative risk (RR) from 0.62 [0.61–0.64] (Europe) to 3.98 [3.82–4.14] (Sri Lanka)). In eight indicators, non-fulfillment was common (>25% among native Danes). Apart from monitoring in the Sri Lanka-group, migrants were at similar or higher risk of non-fulfillment than native Danes across all indicators of monitoring and biomarker control (RR from 0.64 [0.51–0.80] (HbA1c monitoring, Sri Lanka) to 1.78 [1.67–1.90] (LDL-C control, Somalia)), while no overall pattern was observed for pharmacological treatment (RR from 0.61 [0.46–0.80] (GLD, Sri Lanka) to 1.67 [1.34–2.09] (GLD, Somalia)). Care was poorest in migrants from Somalia, who had increased risk in all eleven indicators, and the highest risk in nine. Adjusted risks were elevated in some migrant groups, particularly in indicators of biomarker control (fully-adjusted RR from 0.84 [0.75–0.94] (LDL-C levels, Vietnam) to 1.44 [1.35–1.54] (LDL-C levels, Somalia)). In most migrant groups, T2D was more prevalent, and monitoring and biomarker control was inferior compared to native Danes. Migrants from Somalia received the poorest care overall, and had exceedingly high lipid levels.

7 August 2023 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
AIAnders Aasted Isaksen
Anders Aasted Isaksen
ASAnnelli Sandbæk
Annelli Sandbæk
MSMette Vinther Skriver
Mette Vinther Skriver
LBLasse Bjerg
Lasse Bjerg
Aim: To examine disparities in glucose‐lowering drug (GLD) usage between migrants and native Danes with type 2 diabetes (T2D). Materials and Methods: In a nationwide, register‐based cross‐sectional study of 253 364 individuals with prevalent T2D on December 31, 2018, we examined user prevalence during 2019 of (i) GLD combination therapies and (ii) individual GLD types. Migrants were grouped by origin (Middle East, Europe, Turkey, Former Yugoslavia, Pakistan, Sri Lanka, Somalia, Vietnam), and relative risk (RR) versus native Danes was computed using robust Poisson regression to adjust for clinical and socioeconomic characteristics. Results: In 2019, 34.7% of native Danes received combination therapy, and prevalence was lower in most migrant groups (RR from 0.78, 95% confidence interval CI 0.71‐0.85 [Somalia group] to 1.00, 95% CI 0.97‐1.04 [former Yugoslavia group]). Among native Danes, the most widely used oral GLD was metformin (used by 62.1%), followed by dipeptidyl peptidase‐4 inhibitors (13.3%), sodium‐glucose cotransporter‐2 inhibitors (11.9%) and sulphonylureas (5.2%), and user prevalence was higher in most migrant groups (RR for use of any oral GLD: 0.99, 95% CI 0.97‐1.01 [Europe group] to 1.09, 95% CI 1.06‐1.11 [Sri Lanka group]). Furthermore, 18.7% of native Danes used insulins and 13.3% used glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), but use was less prevalent in migrants (RR for insulins: 0.66, 95% CI 0.62‐0.71 [Sri Lanka group] to 0.94, 95% CI 0.89‐0.99 [Europe group]; RR for GLP‐1RAs: 0.29, 95% CI 0.22‐0.39 [Somalia group] to 0.95, 95% CI 0.89‐1.01 [Europe group]). Conclusions: Disparities in GLD types and combination therapy were evident between migrants and native Danes. Migrants were more likely to use oral GLDs and less likely to use injection‐based GLDs, particularly GLP‐1RAs, which may contribute to complication risk and mortality among this group.

25 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
AIAnders Aasted Isaksen
Anders Aasted Isaksen
JSJonas Rosborg Schaarup
Jonas Rosborg Schaarup
LBLasse Bjerg
Lasse Bjerg
AHAdam Hulman
Adam Hulman
Background Artificial intelligence (AI) is expected to become an integral part of healthcare services, and the widespread adoption of AI tools in all areas of life is making AI accessible to the general public. Public perception of the benefits and risks of AI in healthcare is key to large-scale acceptance and implementation, and is increasingly influenced by first-hand experiences of AI. The aim of this study was to assess how exposure to ChatGPT changed public perception of AI in healthcare. Methods We used baseline and follow-up data from 5,899 survey participants, who reported their perception of AI in 2022 and 2024, and ChatGPT use in 2024. Administrative and healthcare data from nationwide Danish registers was used for weighting and adjustment. Multinomial multivariate logistic regression was used to model how exposure to ChatGPT use affected changes in perception of AI. Results At baseline (before ChatGPT’s launch) 2,236 individuals (37%) were unsure of the benefits and risks of AI in healthcare, 2,384 (40%) perceived net benefits, 1,083 (18%) perceived benefits and risks as equal, and 196 (3.3%) perceived net risks. At follow-up, 1,195 individuals (20%) had been exposed to ChatGPT use, which was associated with higher odds of changing perception of AI to benefits (OR 3.21 [95% CI: 2.34-4.40]) among individuals who were unsure at baseline, and lower odds of changing to uncertainty from more defined baseline perceptions (from benefits (OR 0.32 [0.24-0.42]), equal (OR 0.47 [0.32-0.69]) and risks (OR 0.27 [0.08-0.98])). Conclusion Exposure to ChatGPT was associated with a change towards positive perception of benefits and risks of AI in healthcare among individuals who were uncertain prior to exposure, and individuals with more defined perceptions of AI were less likely to become uncertain after exposure to ChatGPT.

18 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
LLLivie Yumeng Li
Livie Yumeng Li
AIAnders Aasted Isaksen
Anders Aasted Isaksen
BLBenjamin Lebiecka-Johansen
Benjamin Lebiecka-Johansen
KFKristian Funck
Kristian Funck
Vajira Lasantha ThambawitaVajira Lasantha Thambawita
Vajira Lasantha Thambawita
AHAdam Hulman
Adam Hulman
Background Cardiovascular risk prediction models based on sociodemographic factors and traditional clinical measurements have received significant attention. With rapid development in deep learning for image analysis in the last decade and the well-known association between micro- and macrovascular complications, some recent studies focused on the prediction of cardiovascular risk using retinal fundus images. The objective of this scoping review is to identify and describe studies using retinal fundus images and deep learning to predict cardiovascular risk markers and diseases. Methods We searched MEDLINE and Embase for peer-reviewed articles on 17 November 2023. Abstracts and relevant full-text articles were independently screened by two reviewers. We included studies that used deep learning for the analysis of retinal fundus images to predict cardiovascular risk markers (e.g. blood pressure, coronary artery calcification, intima-media thickness) or cardiovascular diseases (prevalent or incident). Studies that used only predefined characteristics of retinal fundus images (e.g. tortuosity, fractal dimension) were not considered. Study characteristics were extracted by the first author and verified by the senior author. Results are presented using descriptive statistics. Results We included 24 articles in the review, published between 2018 and 2023. Among these, 21 (88%) were cross-sectional studies and eight (33%) were follow-up studies with outcome of clinical CVD. Five studies included a combination of both designs. Most studies (n=23, 96%) used convolutional neural networks to process images. We found nine (38%) studies that incorporated clinical risk factors in the prediction and four (17%) that compared the results to commonly used clinical risk scores in a prospective setting. Three of these reported improved discriminative performance. External validation of models was rare (n=5, 21%). Only four (17%) studies made their code publicly available. Conclusions There is an increasing interest in using retinal fundus images in cardiovascular risk assessment. However, there is a need for more prospective studies, comparisons of results to clinical risk scores and models augmented with traditional risk factors. Moreover, more extensive code sharing is necessary to make findings reproducible and more impactful beyond a specific study.